AWHL | tickerfilter.com

Fundamental analysis

40%

Profitability 35%

Dept financing 43%

Liquidity 20%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

20.32%

1 Month

-0.03%

3 Months

-44.44%

6 Months

-32.71%

1 Year

257.04%

2 Year

257.04%

Key data

Stock price

$0.35

P/E Ratio

0.00

DAY RANGE

$0.32 - $0.35

EPS

-$0.29

52 WEEK RANGE

$0.02 - $0.71

52 WEEK CHANGE

$257.04

MARKET CAP

17.475 M

YIELD

N/A

SHARES OUTSTANDING

42.656 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$20,266

AVERAGE 30 VOLUME

$30,392

Company detail

CEO: Nicole Sandford
Region: US
Website: aspirawh.com
Employees: 110
IPO year: 2000

Issue type:
Market: OTCM
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Aspira Women's Health Inc. engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVAInherit tests to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of Gynecologic cancer.

AWHL - Aspira Women's Health Inc.